Investors push biotech Imugene to 13-year price high
SYDNEY: Shares in $620 million biotech Imugene today hit their highest since January 2008 after
SYDNEY: Shares in $620 million biotech Imugene today hit their highest since January 2008 after
FEATURED
How value-based care is changing operations in assisted living sector
Blood test may revolutionise how signs of Alzheimer’s are spotted
Architects designs stepped senior housing to “balance togetherness with independence”
Retirees exploring culture, tattoos and music on a cargo cruise
10-star energy rated display home will help sell it to Boomers
Assisted living providers learn strategies to tackle staffing challenges
INNOVATION
